Ninjacof-D Interactions
There are 560 drugs known to interact with Ninjacof-D (chlophedianol / pseudoephedrine / pyrilamine), along with 13 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 32 are major, 521 are moderate, and 7 are minor.
- View all 560 medications that may interact with Ninjacof-D
- View Ninjacof-D alcohol/food interactions (2)
- View Ninjacof-D disease interactions (13)
Most frequently checked interactions
View interaction reports for Ninjacof-D (chlophedianol / pseudoephedrine / pyrilamine) and the medicines listed below.
- Aimovig (erenumab)
- albuterol
- Allegra (fexofenadine)
- amoxicillin
- Astepro Allergy (azelastine nasal)
- azelastine nasal
- azithromycin
- Emgality (galcanezumab)
- famotidine
- fexofenadine
- fluticasone nasal
- guaifenesin
- hydroxyzine
- Imitrex (sumatriptan)
- ketorolac
- L-Lysine (lysine)
- levothyroxine
- Lexapro (escitalopram)
- magnesium glycinate
- Medrol Dosepak (methylprednisolone)
- metoprolol
- metronidazole
- multivitamin
- Nasacort Allergy 24HR (triamcinolone nasal)
- omeprazole
- Pepcid AC Maximum Strength (famotidine)
- prednisone
- quetiapine
- Singulair (montelukast)
- Sprintec (ethinyl estradiol / norgestimate)
Ninjacof-D alcohol/food interactions
There are 2 alcohol/food interactions with Ninjacof-D (chlophedianol / pseudoephedrine / pyrilamine).
Ninjacof-D disease interactions
There are 13 disease interactions with Ninjacof-D (chlophedianol / pseudoephedrine / pyrilamine) which include:
- depression
- cardiovascular disease
- anticholinergic effects
- asthma/COPD
- cardiovascular
- renal/liver disease
- glaucoma
- liver disease
- GI narrowing
- PKU
- BPH
- diabetes
- glaucoma
Report options
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.